Boston Scientific
As on 18 Apr, 2026 | 01:29 IST
| Open | 63.42 |
| Previous Close | 63.42 |
| Beta | 0.20 |
| High | 64.89 |
| Low | 64.01 |
| TTM EPS See historical trend | 3.05(+21.51% YoY) |
| 52 Week High | 109.50 |
| 52 Week Low | 60.61 |
| TTM PE See historical trend | 21.06(Average PE) |
| Mkt. Cap ($ Billion) | 94.66 |
| Dividend Yield | -- |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 63.83 |
| 10 | 62.92 |
| 20 | 64.79 |
| 50 | 69.95 |
| 100 | 82.33 |
| 200 | 92.27 |
Returns
| 1 Week | 4.02% | |
| 1 Month | -9.74% | |
| 3 Months | -27.12% | |
| YTD | -32.67% | |
| 1 Year | -32.44% | |
| 3 Years | 24.14% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 234.18 | -0.15 | 564.23 | 21.68 | 10.80 | 2.50 | 251.71/146.13 | -1.67 | Very Bullish |
| Abbott | 96.81 | 1.40 | 167.96 | 18.80 | 5.15 | 1.92 | 139.02/93.95 | -12.53 | Very Bearish |
| Intuitive Surgical | 469.21 | 2.43 | 166.30 | 52.54 | 8.93 | -- | 603.70/427.84 | -2.80 | Very Bearish |
| Danaher | 194.77 | 0.51 | 140.68 | 24.97 | 7.80 | 0.56 | 242.75/180.09 | -0.05 | Neutral |
| Stryker | 343.32 | 1.46 | 130.60 | 25.18 | 13.63 | 0.97 | 404.81/319.32 | -1.68 | Neutral |
Market news
- Wall Street skids as Middle East turmoil fans inflation fearMarch 21, 2026 9:02 AM
- Wall Street closes lower, posts weekly loss as war on Iran fuels inflation worriesMarch 14, 2026 8:59 AM
- US stocks close down as oil spikes 12%, job market weakensMarch 7, 2026 9:27 AM
- Wall Street ends higher after Supreme Court rules against Trump tariffsFebruary 21, 2026 8:06 AM
About the company
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.